Back to Search Start Over

Expert perspectives on ECCO2R for acute hypoxemic respiratory failure: consensus of a 2022 European roundtable meeting.

Authors :
Combes, Alain
Auzinger, Georg
Camporota, Luigi
Capellier, Gilles
Consales, Guglielmo
Couto, Antonio Gomis
Dabrowski, Wojciech
Davies, Roger
Demirkiran, Oktay
Gómez, Carolina Ferrer
Franz, Jutta
Hilty, Matthias Peter
Pestaña, David
Rovina, Nikoletta
Tully, Redmond
Turani, Franco
Kurz, Joerg
Harenski, Kai
Source :
Annals of Intensive Care. 8/22/2024, Vol. 14 Issue 1, p1-11. 11p.
Publication Year :
2024

Abstract

Background: By controlling hypercapnia, respiratory acidosis, and associated consequences, extracorporeal CO2 removal (ECCO2R) has the potential to facilitate ultra-protective lung ventilation (UPLV) strategies and to decrease injury from mechanical ventilation. We convened a meeting of European intensivists and nephrologists and used a modified Delphi process to provide updated insights into the role of ECCO2R in acute respiratory distress syndrome (ARDS) and to identify recommendations for a future randomized controlled trial. Results: The group agreed that lung protective ventilation and UPLV should have distinct definitions, with UPLV primarily defined by a tidal volume (VT) of 4–6 mL/kg predicted body weight with a driving pressure (ΔP) ≤ 14–15 cmH2O. Fourteen (93%) participants agreed that ECCO2R would be needed in the majority of patients to implement UPLV. Furthermore, 10 participants (majority, 63%) would select patients with PaO2:FiO2 > 100 mmHg (> 13.3 kPa) and 14 (consensus, 88%) would select patients with a ventilatory ratio of > 2.5–3. A minimum CO2 removal rate of 80 mL/min delivered by continuous renal support machines was suggested (11/14 participants, 79%) for this objective, using a short, double-lumen catheter inserted into the right internal jugular vein as the preferred vascular access. Of the participants, 14/15 (93%, consensus) stated that a new randomized trial of ECCO2R is needed in patients with ARDS. A ΔP of ≥ 14–15 cmH2O was suggested by 12/14 participants (86%) as the primary inclusion criterion. Conclusions: ECCO2R may facilitate UPLV with lower volume and pressures provided by the ventilator, while controlling respiratory acidosis. Since recent European Society of Intensive Care Medicine guidelines on ARDS recommended against the use of ECCO2R for the treatment of ARDS outside of randomized controlled trials, new trials of ECCO2R are urgently needed, with a ΔP of ≥ 14–15 cmH2O suggested as the primary inclusion criterion. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
21105820
Volume :
14
Issue :
1
Database :
Academic Search Index
Journal :
Annals of Intensive Care
Publication Type :
Academic Journal
Accession number :
179167110
Full Text :
https://doi.org/10.1186/s13613-024-01353-8